Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for OSD in Glaucoma Patients
NCT04536129Completed
- Sponsor
- University of Molise
- Start
- Nov 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of Alkindi Sprinkle in ocular surface disease (OSD) (2 arms), sponsored by University of Molise. Primary endpoints: Intraocular pressure at 2 weeks and Ocular Surface Disease Index at 2 weeks. Started Nov 2019; status: completed.
02
Drugs
Alkindi Sprinkle
03
Conditions
ocular surface disease (OSD)
Beyond the preview
Go deeper on NCT04536129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536129.